Merck & Co., Inc.

MRK

Quality scores

Data as of Sep 5, 2026

4 / 9

Neutral

4/9 — middling fundamentals (neutral zone).

PassROA > 0 — ROA last year = 13.34 %
PassFCF > 0 — FCF last year = 12,360.00 mill.
FailFCF > net income (accrual quality) — FCF 12,360.00 vs. net income 18,254.00 (mill.)
FailRising ROA — ROA 13.34 % vs. prior year 14.62 %

FailLower long-term leverage — long-term debt/assets 0.34 vs. prior 0.29
PassRising current ratio (more liquidity) — Current ratio 1.54 vs. prior 1.36
PassNo dilution (shares do not grow) — Shares 2,474.63 mill. vs. prior 2,527.64 mill.

Z-Score (original)

4.53

Safe zone

Z''-Score (non-manufacturing)

7.48

Safe zone

Ratio	Value
X1 — Working capital / Total assets	0.11
X2 — Retained earnings / Total assets	0.53
X3 — EBIT / Total assets	0.16
X4 — Market cap / Total liabilities	4.39
X4 — Book equity / Total liabilities	0.62
X5 — Sales / Total assets	0.47